Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Naloxon

Intranasal Naloxone for Opioid Overdose

Intranasal Naloxone for Opioid Overdose

To identify the key insights or developments described in this article 

In 2021, opioid overdose deaths exceeded 80 000 in the US.1 Naloxone, a competitive opioid receptor antagonist that reverses symptoms of opioid intoxication and overdose by displacing opioids from μ-opioid receptors, is a safe and effective medication for preventing opioid overdose death. Naloxone meets US Food and Drug Administration (FDA) criteria for approval without a prescription: its benefits outweigh risks, it treats a condition that can be identified by people in the community, it has a low potential for misuse, and it can be labeled to facilitate correct administration. (AMA – American Medical Association, JAMA Network, USA, 

https://edhub.ama-assn.org/jn-learning/module/2813503